Home › Immunoglobulin Light-chain Amyloidosis › Utah
Immunoglobulin Light-chain Amyloidosis clinical trials in Utah
3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Utah.
Cities in Utah
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- GSK Investigational Site, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224672Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- University of Utah, Huntsman Cancer Hospital, Salt Lake City
RecruitingObservational study
Ages 40 and older · All sexes · Updated Oct 26, 2026 · NCT06365060Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05145816From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.